Reboxetine
Description
Reboxetine is an anti-depressant used for the acute treatment of depressive illness or major depression, including relapse of symptoms. This medicine is not recommended for use in patients below 18 years of age.
QUICK LINKS:
Side effects
Major & minor side effects for Reboxetine
- Insomnia
- Dizziness
- Dry mouth
- Constipation
- Nausea and Vomiting
- Sweating
- Headache
- Loss of appetite
- Lack of visual focus
- Rash
- Dilated pupils
Uses of Reboxetine
What is it prescribed for?
- Major depression
Read More
Concerns
Commonly asked questions
- Onset of actionThe amount of time required for this medicine to show its action is not clinically established.
- Duration of effectThe amount of time for which this medicine remains active in the body is not clinically established.
- Safe with alcohol?Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
- Is it habit forming?No habit-forming tendencies were reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
- Usage while breast-feeding?This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
Allergy
This medicine is not recommended for use in patients with a known allergy to reboxetine or any other inactive ingredients present along with it.
Narrow angle glaucoma
This medicine is not recommended for use in patients with narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.
Monoamine oxidase inhibitors (MAO)
This medicine is not recommended for use in patients receiving Monoamine oxidase inhibitors due to the increased risk of severe adverse effects.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
General warnings
Use in children
This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.
Epilepsy
This medicine should be used with caution in patients with a known history of epilepsy or convulsions due to the increased risk of worsening of the patient's condition. Treatment should be stopped immediately if any incidence of convulsions occurs. Replacement with a suitable alternative should be considered under your doctor's supervision.
Liver impairment
This medicine should be used with caution in patients with liver function impairment due to the increased risk of adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Renal impairment
This medicine should be used with caution in patients with kidney function impairment due to the increased risk of adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Suicidal thoughts
Use of this medicine may cause suicidal thoughts and change the behavior of some patients. This risk is especially high in patients below the age of 25 years. It is recommended to screen the patients for such behavior/thoughts before initiating treatment with this medicine. Patients should be monitored closely for any changes in behavior/mood. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
Drowsiness
This medicine may cause drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you feel drowsy during treatment with this medicine.
Missed Dose
Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Azole antifungal agents
Ergotamine
Phenobarbital
Macrolide antibiotics
Carbamazepine
Disease interactions
Glaucoma
This medicine should be used with extreme caution in patients suffering from glaucoma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Report any unusual symptoms to the doctor immediately. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous
How it works
This medicine works by affecting the level of certain specific chemicals that are imbalanced in patients with depression.
Legal Status
Classification
Category
Selective noradrenaline reuptake inhibitor (SNRI)
Schedule
Schedule H
[Internet]. 2018 [cited 11 January 2018]. Available from:
[Internet]. Secure.healthlinks.net.au. 2018 [cited 11 January 2018]. Available from:
[Internet]. Labeling.pfizer.com. 2018 [cited 11 January 2018]. Available from:
[Internet]. 2018 [cited 11 January 2018]. Available from:
Reboxetine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 12 January 2018]. Available from:
Information on this page was last updated on 31 Jan 2018
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.